See more : Huber+Suhner AG (HUBN.SW) Income Statement Analysis – Financial Results
Complete financial analysis of Sinphar Pharmaceutical Co.,Ltd. (1734.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sinphar Pharmaceutical Co.,Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
- Mazaya Real Estate Development Q.P.S.C. (MRDS.QA) Income Statement Analysis – Financial Results
- Ichor Holdings, Ltd. (0Z0F.L) Income Statement Analysis – Financial Results
- Creative Newtech Limited (CREATIVE.NS) Income Statement Analysis – Financial Results
- Space-Communication Ltd (SPMMF) Income Statement Analysis – Financial Results
- Bosch Limited (BOSCHLTD.NS) Income Statement Analysis – Financial Results
Sinphar Pharmaceutical Co.,Ltd. (1734.TW)
About Sinphar Pharmaceutical Co.,Ltd.
Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, researches, develops, manufactures, and sells therapeutic drugs, health care foods, and medical beauty products in Taiwan and internationally. It produces anti-cancer pharmaceuticals, such as injections, solid reagents, and hormone reagents; and tablets, soft gel capsules and powder and canned special nutrient products. The company also offers shampoo, body wash, tonic water, lotions, moisturizers, sunscreen lotions, and serums; and pharmaceutical packaging products, such as eye drop bottles, dry canisters, tablet bottles, and various medical grade plastic containers. In addition, it provides plant extracts and functional foods; and OEM services, such as product design, manufacturing, etc. to manufacturers. The company was founded in 1977 and is headquartered in Yilan City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.96B | 2.86B | 2.43B | 2.39B | 2.39B | 2.22B | 2.13B | 2.13B | 2.19B | 2.64B | 2.58B | 2.09B | 1.84B | 1.82B | 1.81B |
| Cost of Revenue | 1.87B | 1.77B | 1.54B | 1.51B | 1.45B | 1.39B | 1.32B | 1.34B | 1.40B | 1.56B | 1.61B | 1.31B | 1.15B | 1.13B | 1.09B |
| Gross Profit | 1.09B | 1.09B | 888.71M | 875.53M | 940.85M | 825.38M | 810.26M | 789.91M | 785.98M | 1.08B | 964.28M | 772.01M | 693.80M | 694.17M | 723.89M |
| Gross Profit Ratio | 36.92% | 38.20% | 36.52% | 36.66% | 39.29% | 37.25% | 37.97% | 37.02% | 35.93% | 41.01% | 37.41% | 37.00% | 37.70% | 38.09% | 39.92% |
| Research & Development | 132.58M | 272.16M | 511.88M | 462.40M | 527.81M | 376.38M | 363.49M | 382.61M | 343.40M | 350.27M | 225.85M | 176.36M | 185.20M | 151.96M | 133.48M |
| General & Administrative | 224.15M | 213.06M | 201.60M | 209.10M | 234.06M | 252.23M | 229.11M | 229.95M | 258.80M | 276.70M | 240.58M | 175.65M | 148.40M | 135.49M | 151.68M |
| Selling & Marketing | 446.78M | 408.27M | 355.46M | 328.06M | 324.73M | 316.07M | 280.68M | 319.52M | 312.05M | 312.36M | 335.34M | 298.06M | 297.55M | 309.38M | 303.83M |
| SG&A | 670.93M | 621.34M | 557.06M | 537.16M | 558.79M | 568.30M | 509.79M | 549.47M | 570.85M | 589.06M | 575.92M | 473.71M | 445.96M | 444.87M | 455.51M |
| Other Expenses | 4.36M | 69.75M | 19.36M | 25.13M | 83.38M | 40.75M | 33.08M | 57.86M | 90.28M | 83.34M | 266.04M | 54.20M | 40.56M | 44.23M | 30.43M |
| Operating Expenses | 807.87M | 893.50M | 1.07B | 999.56M | 1.09B | 944.68M | 873.29M | 932.07M | 914.25M | 939.33M | 801.77M | 650.07M | 631.16M | 596.83M | 588.98M |
| Cost & Expenses | 2.68B | 2.66B | 2.61B | 2.51B | 2.54B | 2.34B | 2.20B | 2.28B | 2.32B | 2.50B | 2.42B | 1.96B | 1.78B | 1.73B | 1.68B |
| Interest Income | 12.31M | 5.78M | 3.68M | 3.80M | 3.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.48M | 1.91M | 623.00K | 1.02M |
| Interest Expense | 33.71M | 27.81M | 24.80M | 24.51M | 23.12M | 20.44M | 20.74M | 21.80M | 20.67M | 20.27M | 18.56M | 17.19M | 14.67M | 13.36M | 21.11M |
| Depreciation & Amortization | 243.52M | 266.71M | 269.37M | 250.42M | 236.77M | 238.80M | 238.99M | 259.34M | 227.13M | 193.01M | 168.34M | 162.97M | 162.05M | 145.27M | 131.54M |
| EBITDA | 582.94M | 539.57M | 109.64M | 157.16M | 173.18M | 171.56M | 206.92M | 246.21M | 188.42M | 420.64M | 596.89M | 328.51M | 266.20M | 282.12M | 293.91M |
| EBITDA Ratio | 19.67% | 18.90% | 4.61% | 6.50% | 7.28% | 7.23% | 9.79% | 11.84% | 8.65% | 15.92% | 23.15% | 16.15% | 14.47% | 15.67% | 16.11% |
| Operating Income | 286.06M | 273.33M | -157.19M | -95.09M | -62.37M | -119.30M | -63.03M | -142.16M | -128.27M | 144.30M | 162.51M | 121.94M | 62.65M | 97.34M | 134.91M |
| Operating Income Ratio | 9.65% | 9.57% | -6.46% | -3.98% | -2.60% | -5.38% | -2.95% | -6.66% | -5.86% | 5.46% | 6.30% | 5.84% | 3.40% | 5.34% | 7.44% |
| Total Other Income/Expenses | 19.65M | 47.71M | -1.76M | 4.42M | 60.26M | 31.62M | 10.22M | 107.23M | 69.61M | 63.07M | 247.48M | 22.17M | 26.83M | 26.16M | 6.34M |
| Income Before Tax | 305.71M | 245.05M | -184.53M | -117.77M | -86.71M | -87.68M | -52.81M | -34.92M | -58.66M | 207.37M | 409.99M | 145.28M | 89.48M | 123.50M | 141.25M |
| Income Before Tax Ratio | 10.32% | 8.58% | -7.58% | -4.93% | -3.62% | -3.96% | -2.47% | -1.64% | -2.68% | 7.85% | 15.90% | 6.96% | 4.86% | 6.78% | 7.79% |
| Income Tax Expense | -51.07M | 80.87M | 20.43M | 54.79M | 61.22M | 35.32M | 37.36M | 29.25M | 24.87M | 108.41M | 85.25M | 37.80M | 25.55M | 21.10M | 28.92M |
| Net Income | 375.17M | 164.17M | -204.96M | -172.56M | -147.92M | 8.79M | 36.73M | 16.55M | 13.95M | 163.39M | 300.69M | 121.30M | 72.23M | 110.93M | 131.03M |
| Net Income Ratio | 12.66% | 5.75% | -8.42% | -7.22% | -6.18% | 0.40% | 1.72% | 0.78% | 0.64% | 6.18% | 11.66% | 5.81% | 3.92% | 6.09% | 7.23% |
| EPS | 2.24 | 0.98 | -1.22 | -1.03 | -0.88 | 0.05 | 0.22 | 0.10 | 0.08 | 0.97 | 1.79 | 0.74 | 0.49 | 0.77 | 0.98 |
| EPS Diluted | 2.07 | 0.98 | -1.22 | -1.03 | -0.88 | 0.05 | 0.22 | 0.10 | 0.08 | 0.97 | 1.79 | 0.74 | 0.48 | 0.76 | 0.90 |
| Weighted Avg Shares Out | 167.72M | 167.72M | 167.72M | 167.72M | 167.72M | 167.72M | 167.72M | 167.72M | 167.72M | 167.72M | 167.72M | 167.71M | 148.44M | 144.63M | 134.26M |
| Weighted Avg Shares Out (Dil) | 181.47M | 168.01M | 167.72M | 167.72M | 167.85M | 167.79M | 167.82M | 167.72M | 167.72M | 167.72M | 167.72M | 167.72M | 149.07M | 146.33M | 145.03M |
Source: https://incomestatements.info
Category: Stock Reports